If this was the case, we would expect that women being treated for severe COVID-19 infections in intensive care would have lower KDM6A expression than those with infections not requiring such care.15 We examined the RNA-seq data from blood samples of 102 COVID-19 patients. This evidence concerns the gene KDM6A and COVID-19.